Market experts have issued a buy recommendation for Mahindra & Mahindra with a current market price of ₹3,334. According to Ruchit Jain, head of technical research at Motilal Financial Services Ltd., the stock has clearly outperformed and suggests a staggered approach to accumulate the shares. The recommendation is based on expectations of stronger second quarter performance and potential improvement in profitability. As reported by NDTV Profit, Jain noted that the second quarter could be stronger and could see profitability getting better.
Experts recommend holding TVS Motor shares at the current market price of ₹4,304.20. Avinash Gorakshakar, founder of Avinashmentor.com, highlighted that the company's products are well established and volume growth has always outperformed industry growth. The entire two-wheeler segment is going in double digits, and investors should not worry about market volatility. According to the expert analysis on NDTV Profit, the recommendation emphasizes that markets only look at earnings disappointment, and investors should continue to hold the stock.
Ruchit Jain from Motilal Financial Services Ltd. recommends avoiding Biocon from a short-term perspective, with the stock trading at ₹411.10. As reported by NDTV Profit, Jain prefers Glenmark Pharma over Biocon for investment considerations. The recommendation suggests that investors should avoid Biocon for short-term investment strategies.
Market experts recommend holding Coforge shares at the current market price of ₹2,104.60. Gorakshakar from Avinashmentor.com noted that Coforge is one of the tier-2 IT stocks whose performance has been very solid for the last two quarters. The company has demonstrated remarkable momentum with Coforge shares gaining 12% over the past month, outperforming the 0.5% drop in the BSE Infotech index. The stock ended Tuesday's session at ₹1,983 on the BSE, reflecting strong investor confidence. For the June quarter, revenue grew by 24.2% sequentially to ₹5,527 crore, helped by the integration of recently acquired Encora. The company's margin profile has improved significantly with operating margin expanding by 414 basis points year-on-year to 16%.
Coforge's business momentum has been exceptional with the company booking $691 million worth of new deals in the June quarter compared with $507 million in the year-ago quarter. This took the total executable order book to $2,228 million from $1,545 million by similar comparison. The company has successfully ramped up the $158 million worth deal announced in April, while the $230 million deal announced in the current quarter is in the initiation stage. Analysts have responded positively, with JM Financial revising earnings estimates for FY27-29 by 6-9% and increasing the target price to ₹1,795 from ₹1,610. Axis Securities has raised the FY28 forward P/E multiple to 30 from 26, implying a higher price target of ₹2,275 from earlier ₹1,690.
